Tumor xenografts are the most common models to study human cancer. The model require the implantation of tumor derived cells in animal hosts. In 1990, it was found that the co-injection of Basement Membrane Matrix or Cultrex BME with tumor cells improved tumor take and growth. Now Trevigen has developed, produced, and qualified Cultrex Basement Membrane Matrix BME Type 3, a type of BME that mimics the tumor microenvironment and that is specifically designed for use in in vivo studies. In addition, Trevigen offers a Technical Tip, a webinar and literature with useful information to improve your xenograft model.

Learn more about Trevigen Xenograft, Tumorgraft, and PDX products and resources.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories